Clinic for Angiology, Swiss Cardiovascular Center, Inselspital, University Hospital, University of Bern, 3010 Bern, Switzerland.
Eur Heart J. 2014 Mar;35(12):758-64. doi: 10.1093/eurheartj/ehu029. Epub 2014 Feb 3.
Pulmonary embolism remains a common and potentially life-threatening disease. For patients with intermediate- and high-risk pulmonary embolism, catheter-based revascularization therapy has emerged as potential alternative to systemic thrombolysis or surgical embolectomy. Ultrasound-assisted catheter-directed thrombolysis is a contemporary catheter-based technique and is the focus of the present review. Ultrasound-assisted catheter-directed thrombolysis is more effective in reversing right ventricular dysfunction and dilatation in comparison with anticoagulation alone in patients at intermediate risk. However, a direct comparison of ultrasound-assisted thrombolysis with systemic thrombolysis or surgical thrombectomy is not available. Ultrasound-assisted thrombolysis with initial intrapulmonary thrombolytic bolus may also be effective in high-risk patients, but evidence from randomized trials is not available. This review summarizes current data on ultrasound-assisted thrombolysis for acute pulmonary embolism.
肺栓塞仍然是一种常见且可能危及生命的疾病。对于中高危肺栓塞患者,基于导管的血运重建治疗已成为全身溶栓或手术取栓的潜在替代方法。超声辅助导管定向溶栓是一种现代的基于导管的技术,是本综述的重点。与单独抗凝相比,超声辅助导管定向溶栓在中危患者中更有效地逆转右心室功能障碍和扩张。然而,目前尚无超声辅助溶栓与全身溶栓或手术血栓切除术的直接比较。初始肺内溶栓剂冲击剂量的超声辅助溶栓也可能对高危患者有效,但随机试验的证据尚不可用。这篇综述总结了急性肺栓塞超声辅助溶栓的最新数据。